DecisionHealth, DecisionHealth - 2024 Issue 10 (October)
HHS issues RFI for Part D ‘$2 drugs’ on some widely-used prescriptions
Adding to its other pioneering prescription drug programs under Medicare, the Biden administration announced Oct. 9 that it would issue a request for information (RFI) on a potential “Medicare $2 Drug List Model” that would make some much-used drugs for hypertension, high cholesterol and other common conditions available to Part D beneficiaries for a couple of bucks.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.
Thank you for choosing Find-A-Code, please Sign In to remove ads.